Search research articles
Contact Us
Filters
Showing results (721-730 of 729) with videos related to
Page
of 73
Sort By:
You have reached the last page of results.
This site can display upto 729 results.
Breast Cancer Research and Treatment
|
March 23, 2026
Risk of CNS relapse following pathological complete response to neoadjuvant chemotherapy in early breast cancer
Luciana de Moura Leite, Guilherme Rossato de Almeida, Monique Celeste Tavares, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 14, 2015
Neuroendocrine tumors, version 1.2015
Matthew H Kulke, Manisha H Shah, Al B Benson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 9, 2012
Neuroendocrine tumors
Matthew H Kulke, Al B Benson, Emily Bergsland, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 15, 2018
NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018
Robert I Haddad, Christian Nasr, Lindsay Bischoff, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 10, 2022
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Robert I Haddad, Lindsay Bischoff, Douglas Ball, et al.
JCO Oncology Practice
|
March 6, 2026
Clinical Impact and Clinicopathologic Correlations of Oncotype DX in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Real-World Evidence From a Large Brazilian Cohort (GBECAM 0520)
Leandro Jonata de Carvalho Oliveira, Daniella Castro Araújo, Júlio Antonio Pereira de Araújo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 2, 2021
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Manisha H Shah, Whitney S Goldner, Al B Benson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 13, 2018
NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018
Manisha H Shah, Whitney S Goldner, Thorvardur R Halfdanarson, et al.
Breast (Edinburgh, Scotland)
|
August 6, 2025
Cancer outcomes in patients eligible for adjuvant cyclin-dependent kinase 4 and 6 inhibitors but spared adjuvant chemotherapy by Oncotype Dx: A multicenter retrospective GBECAM 0520 study
Leandro Jonata de Carvalho Oliveira, Daniela Dornelles Rosa, Artur Katz, et al.
Page
of 73
Search research articles
Search
Showing results (721-730 of 729) with videos related to
Sort By:
Page
of 73
You have reached the last page of results.
This site can display upto 729 results.
Breast Cancer Research and Treatment
|
March 23, 2026
Risk of CNS relapse following pathological complete response to neoadjuvant chemotherapy in early breast cancer
Luciana de Moura Leite, Guilherme Rossato de Almeida, Monique Celeste Tavares, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 14, 2015
Neuroendocrine tumors, version 1.2015
Matthew H Kulke, Manisha H Shah, Al B Benson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 9, 2012
Neuroendocrine tumors
Matthew H Kulke, Al B Benson, Emily Bergsland, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 15, 2018
NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018
Robert I Haddad, Christian Nasr, Lindsay Bischoff, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 10, 2022
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Robert I Haddad, Lindsay Bischoff, Douglas Ball, et al.
JCO Oncology Practice
|
March 6, 2026
Clinical Impact and Clinicopathologic Correlations of Oncotype DX in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Real-World Evidence From a Large Brazilian Cohort (GBECAM 0520)
Leandro Jonata de Carvalho Oliveira, Daniella Castro Araújo, Júlio Antonio Pereira de Araújo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 2, 2021
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Manisha H Shah, Whitney S Goldner, Al B Benson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 13, 2018
NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018
Manisha H Shah, Whitney S Goldner, Thorvardur R Halfdanarson, et al.
Breast (Edinburgh, Scotland)
|
August 6, 2025
Cancer outcomes in patients eligible for adjuvant cyclin-dependent kinase 4 and 6 inhibitors but spared adjuvant chemotherapy by Oncotype Dx: A multicenter retrospective GBECAM 0520 study
Leandro Jonata de Carvalho Oliveira, Daniela Dornelles Rosa, Artur Katz, et al.
Page
of 73